Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Current Liabilities -----

What is the latest Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Current Liabilities ratio of NATH BIOGENES (INDIA) is - based on Mar2024 Consolidated results.
Year Current Liabilities
Mar2024-
Mar2023-
Mar2022-
Mar2013-
Mar2012-

How is Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Current Liabilities % Change
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2013 -
0
Mar2012 - -

Compare Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹375.3 Cr -4.4% 3.4% -0.8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,113.6 Cr -4% -5% 14.3% Stock Analytics
KAVERI SEED COMPANY ₹6,403.9 Cr -4.2% -15% 33.8% Stock Analytics
VENKYS (INDIA) ₹2,255.7 Cr -1.3% -0.4% -21.3% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,418.8 Cr -3.9% -1.8% -30.6% Stock Analytics
INDO US BIOTECH ₹303.6 Cr 0.4% 2.2% -30.7% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-4.4%

3.4%

-0.8%

SENSEX

0.1%

1.2%

6%


You may also like the below Video Courses